Observational Study on Effectiveness and Safety of Liraglutide in Subjects With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Novo Nordisk A/S
Related studies linked through entity extraction aliases.
Observational Study on the Use of NovoSeven® for Haemostatic Treatment of Bleeding Episodes in Patients With Acquired Haemophilia
- Status
- COMPLETED
- Phase
- N/A
Efficacy of NNC109-0012 in Subjects With Active Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE2
Association Between Glycaemic Control and Morbi/Mortality After 5 Years of Follow-up in Type 2 Diabetic Patients
- Status
- UNKNOWN
- Phase
- N/A
Comparison of Biphasic Insulin Aspart 30 Twice Daily With Two Different Initial Dosage Split Regimens in Subjects With Type 2 Diabetes: An Extension to Trial BIASP-3756
- Status
- COMPLETED
- Phase
- PHASE4
Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NN9924 in Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweight Subjects With Co-morbidities: SCALE™ - Obesity and Pre-diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Investigating Safety and Pharmacokinetics of NNC 0128-0000-2011 Compared to NNC 0128-0000-2021 in Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Comparison of NN5401 With Insulin Glargine in Insulin Naive Subjects With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
LIraglutide and Beta-cell RepAir (LIBRA) Study
- Status
- COMPLETED
- Phase
- PHASE3
Comparing Insulin Aspart With Fast-acting Insulin Human in Subjects With Type 1 Diabetes
- Status
- COMPLETED
- Phase
- PHASE1
First Human Dose Study of Anti-IL-20 in Psoriasis: A Study of Safety, Tolerability and Early Signals of Biologic and Clinical Effects
- Status
- TERMINATED
- Phase
- PHASE1
Safety and Efficacy of Monthly Replacement Therapy With Recombinant Factor XIII (rFXIII) in Paediatric Subjects With Congenital Factor XIII A-subunit Deficiency
- Status
- COMPLETED
- Phase
- PHASE3
Reversibility of Dual Antiplatelet Therapy by Platelets
- Status
- COMPLETED
- Phase
- PHASE2
Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents
- Status
- COMPLETED
- Phase
- PHASE4
Investigation of the Pharmacokinetic Properties of Biphasic Insulin Aspart 50 in Healthy Chinese Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Insulin Detemir in Obesity Management
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
A Single Dose Trial of Recombinant Factor VIII (N8) in Japanese Subjects With Haemophilia A: An Extension to Trial NN7008-3543
- Status
- COMPLETED
- Phase
- PHASE1
Liraglutide Efficacy and Action in Non-Alcoholic Steatohepatitis
- Status
- COMPLETED
- Phase
- PHASE2